Evidence map›Paper›PMID 36239807›Full record

ArticleProtoplasma2023

Kinetin induces microtubular breakdown, cell cycle arrest and programmed cell death in tobacco BY-2 cells.

Andrzej Kaźmierczak, Ewa Siatkowska, Ruoxi Li, Sophie Bothe, Peter Nick

Abstract read
In one paragraph

Article in Protoplasma, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Andrzej KaźmierczakFaculty of Biology and Environmental Protection, Institute of Experimental Biology, Department of Cytophysiology, University of Łódź, Pomorska 141/143, 90-236, Lodz, Poland.ORCID http://orcid.org/0000-0001-6446-7337
Ewa SiatkowskaFaculty of Biology and Environmental Protection, Institute of Experimental Biology, Department of Cytophysiology, University of Łódź, Pomorska 141/143, 90-236, Lodz, Poland.
Ruoxi LiBotanical Institute, Karlsruhe Institute of Technology, Fritz-Haber-Weg 4, 76131, Karlsruhe, Germany.
Sophie BotheBotanical Institute, Karlsruhe Institute of Technology, Fritz-Haber-Weg 4, 76131, Karlsruhe, Germany.
Peter NickBotanical Institute, Karlsruhe Institute of Technology, Fritz-Haber-Weg 4, 76131, Karlsruhe, Germany. peter.nick@kit.edu.

Funding

University of Łódź 1409
6 · The paper itself

Abstract

Plant cells can undergo regulated cell death in response to exogenous factors (often in a stress context), but also as regular element of development (often regulated by phytohormones). The cellular aspects of these death responses differ, which implies that the early signalling must be different. We use cytokinin-induced programmed cell death as paradigm to get insight into the role of the cytoskeleton for the regulation of developmentally induced cell death, using tobacco BY-2 cells as experimental model. We show that this PCD in response to kinetin correlates with an arrest of the cell cycle, a deregulation of DNA replication, a loss of plasma membrane integrity, a subsequent permeabilisation of the nuclear envelope, an increase of cytosolic calcium correlated with calcium depletion in the culture medium, an increase of callose deposition and the loss of microtubule and actin integrity. We discuss these findings in the context of a working model, where kinetin, mediated by calcium, causes the breakdown of the cytoskeleton, which, either by release of executing proteins or by mitotic catastrophe, will result in PCD.

Indexed as

CalciumNicotianaApoptosisCell Cycle CheckpointsKinetinCalciumKinetinCalloseCell cycle arrestKinetinMicrotubulesProgrammed cell deathTobacco BY-2

Identifiers

PMID36239807
PMCPMC10125952

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.